Similar articles

• Cost analysis of dialysis treatments for end-stage renal disease (ESRD).

  Goeree R, Manalich J, Grootendorst P, Beecroft ML, Churchill DN. Goeree R, et al. Clin Invest Med. 1995 Dec;18(6):455-64. Clin Invest Med. 1995. PMID: 8714789
• Trends in Medicare reimbursement for end-stage renal disease: 1974-1979.

  Eggers PW. Eggers PW. Health Care Financ Rev. 1984 Fall;6(1):31-8. Health Care Financ Rev. 1984. PMID: 10310848 Free PMC article.
• The Medicare cost of renal dialysis. Evidence from a statistical cost function.

  Dor A, Held PJ, Pauly MV. Dor A, et al. Med Care. 1992 Oct;30(10):879-91. doi: 10.1097/00005650-199210000-00001. Med Care. 1992. PMID: 1405794
• Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of home versus hospital or satellite unit haemodialysis for people with end-stage renal failure.

  Mowatt G, Vale L, Perez J, Wyness L, Fraser C, MacLeod A, Daly C, Stearns SC. Mowatt G, et al. Health Technol Assess. 2003;7(2):1-174. doi: 10.3310/hta7020. Health Technol Assess. 2003. PMID: 12773260 No abstract available.
• Home haemodialysis dose: how much of a good thing?

  Pickering W. Pickering W. J Ren Care. 2013 Jan;39 Suppl 1:35-41. doi: 10.1111/j.1755-6686.2013.00344.x. J Ren Care. 2013. PMID: 23464912 Review.